Clinical trials
Gastrointestinal clinical trials
Below are recruiting gastrointestinal clinical trials, each written for real people, not researchers. We’re tracking 482 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07133620Recruiting
Electrical acupoint stimulation for better recovery after urologic surgery
This trial tests if using mild electrical stimulation on specific acupoints (similar to acupuncture without needles) can help your stomach and bowels get back to normal faster after laparoscopic kidney or prostate surgery.
Xiamen, FujianAges 18 years+ - NCT07607249Enrolling by invitation
Floating Needle Treatment for Stomach Issues After Knee Surgery
This trial tests whether a traditional Chinese acupuncture technique called 'floating needle' can help with stomach and bowel problems that sometimes happen after knee surgery under general anesthesia. You would receive this treatment along with standard post-surgery care to see if it reduces nausea, constipation, or other digestive issues.
Guangzhou, GuangdongAges 18 years+ - NCT07453823Recruiting
Synbiotic for gut health in overweight adults
This trial tests a combination supplement (a synbiotic) to see if it can improve gut function and gut bacteria in middle-aged and older adults who are overweight and have constipation. If eligible, you take the supplement daily and report how your digestion feels.
Cork, BlackpoolAges 50–70 - NCT07625189Recruiting
Registry tracking EUS-guided ablation for pancreatic and digestive lesions
This registry collects information about patients receiving a specialized procedure called EUS-guided ablation—using heat to destroy abnormal growths in the pancreas and digestive tract. By tracking your care, researchers aim to better understand how effective and safe this treatment is.
Morgantown, West VirginiaAges 18 years+ - NCT07707258Recruiting
Remimazolam with oliceridine for sedation in older adults during GI endoscopy
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
Shanghai, Shanghai MunicipalityAges 65–80 - NCT07589465Recruiting
Lactulose to Help Digestion Recover After Appendix Surgery
This study tests whether taking lactulose (a gentle laxative) after appendix removal helps your stomach and intestines work normally again. The trial compares lactulose to a placebo (inactive pill) to see which helps patients recover bowel function faster.
SichuanAges 18 years+ - NCT06070740RecruitingPhase 2
Durvalumab Plus Chemo for Advanced Gastrointestinal NEC
This trial tests a combination of durvalumab (an immunotherapy drug) plus a chemotherapy called XELOX as the first treatment for advanced gastrointestinal neuroendocrine carcinoma (NEC). It aims to see if the combination works better than chemo alone.
Beijing, Beijing MunicipalityAges 18–75 - NCT06604156Recruiting
Anesthesia based on pain monitoring for painless GI endoscopy
This study tests a new way to give anesthesia during painless upper and lower GI exams by using a special monitor that tracks your body's response to pain. The goal is to make the procedure more comfortable and safer for you.
Chongqing, Chongqing MunicipalityAges 18–60 - NCT07425249Recruiting
Chewing gum after stomach or bowel surgery
This trial tests if chewing gum after open stomach or bowel surgery can help your intestines start moving again sooner. It is for people undergoing open gastrointestinal surgery who do not have certain health conditions or take specific medicines.
Peshawar, KPKAges 17–85 - NCT07492693RecruitingPhase 2
Preventing low platelets from chemo in GI cancers
This trial tests if hetrombopag can prevent low platelet counts caused by chemotherapy in people with gastrointestinal cancers. It may help reduce the risk of bleeding and the need for platelet transfusions.
ShanghaiAges 18 years+ - NCT07355634Recruiting
Terraflora daily care for gut health
This trial tests if a daily probiotic supplement, Terraflora, can improve gut health in people with an imbalance of gut bacteria (dysbiosis). You may join if you're an adult with a stool test showing dysbiosis and are not taking certain other medications or supplements.
Richmond, VirginiaAges 25 years+ - NCT07388264Recruiting
Probiotic for bloating and gut health
This study tests a probiotic (a good bacteria) called Weizmannia coagulans to see if it helps reduce bloating and improves gut health. Researchers will check how your digestion changes by looking at your stool and gut bacteria.
Saint Charles, MissouriAges 18–50 - NCT07081100Recruiting
Probiotics for stomach and bowel health improvement
This trial tests whether a probiotic supplement can help people with common stomach or bowel issues like indigestion or constipation that are not caused by another disease. You take the probiotic daily to see if it improves your symptoms.
Suzhou, JiangsuAges 18–65 - NCT07622849Enrolling by invitation
Fecal Microbiota Transplant for Transplant-Related Intestinal Damage
This trial tests whether transferring healthy gut bacteria from a donor to patients can help heal severe intestinal damage that occurs after bone marrow or stem cell transplants. The goal is to reduce pain, inflammation, and other complications from this serious side effect.
Suzhou, JiangsuAges 15–65 - NCT06721195Recruiting
Study of Euphoria from Remimazolam During GI Scopes
This trial studies a sedative called remimazolam and how it makes people feel during routine upper and lower GI scope procedures. It may help doctors understand which patients are more likely to feel a sense of euphoria (a feeling of intense happiness) from the medicine.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06697691Recruiting
Predicting rebleeding risk after upper gut bleeding
This study aims to create a tool that helps doctors predict if a patient with upper gut bleeding (not from veins) will rebleed while still in the hospital. It uses information from your hospital stay to better understand your risk and improve care.
Wuhan, HubeiAges 18 years+ - NCT06644274Recruiting
PET scan for tracking immunotherapy in gastrointestinal cancers
This trial uses a special PET scan called 68Ga-grazytracer to see how well immunotherapy is working in people with stomach, colon, or other gastrointestinal cancers. The goal is to find out if this scan can help doctors track your response to treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06417567Recruiting
Preventing nausea and vomiting after GI cancer surgery
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06529159Recruiting
Treating H. pylori with argon plasma during endoscopy
This trial tests a new way to treat H. pylori infection using argon plasma (a kind of energy) during an upper endoscopy. It may help people who haven't yet taken antibiotics for H. pylori and are already having an endoscopy.
Boston, MassachusettsAges 18 years+ - NCT04960072RecruitingEarly Phase 1
Study of lab-grown T cells for gastrointestinal cancer
This trial tests GC101 tumor-infiltrating lymphocytes (TILs), which are special immune cells collected from a tumor, grown in a lab, and given back to treat gastrointestinal cancers that have returned or spread. It may help your immune system better attack the cancer, especially when standard treatments have not worked.
ShanghaiAges 18–75 - NCT07564466RecruitingPhase 2
SKB571 treatment for gastrointestinal tumors
This study tests a new drug called SKB571 in people with stomach, intestinal, or related cancers. The goal is to see if it can shrink tumors and help patients live longer.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07539311RecruitingPhase 2
Testing Rina-S for Advanced Gastrointestinal Cancers
This study tests a new drug called Rina-S in people with advanced gastrointestinal cancers (like stomach, colon, or pancreatic cancer) that have spread or cannot be surgically removed. The drug is designed to help slow or stop cancer growth in people whose cancer has gotten worse despite recent treatment.
Grand Rapids, MichiganAges 18 years+ - NCT06885034RecruitingPhase 1/Phase 2
Testing a New Drug for Advanced Colon, Rectal, or Pancreatic Cancer
This study tests an experimental drug, alone or combined with other treatments, for advanced colon, rectal, or pancreatic cancer that hasn't responded to standard options or cannot be removed by surgery. The goal is to see if it is safe and if it helps shrink or slow the cancer.
Los Alamitos, CaliforniaAges 18 years+ - NCT07712107Recruiting
Gastrointestinal Cancer Screening Study Using Combined Detection
This study tests a new way to screen for stomach and digestive cancers using a combination of tests. It compares different screening plans to see which works best for people in their middle years.
Zhaoqing, GuangdongAges 45–74
Hear when a new Gastrointestinal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastrointestinal?
- Yes. Clin2 currently lists 482 recruiting gastrointestinal studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastrointestinal trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastrointestinal trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.